Baxter expects to reach 100% allocation across several IV product codes by the end of 2023. The company plans to increase production capacity through phased updates in late November, mid-December and ...

Baxter expects to restart a second IV solutions manufacturing line within the next week, the company announced Nov. 7. Along ...

The company, which is a key producer for American healthcare providers, was hit by the hurricane when it tore through western ...

Baxter, a health care solutions manufacturer headquartered in Illinois, has been making progress on reopening one of its ...

CFO Joel Grade told investors Friday that Baxter expects an approximately $200 million hit to sales in the fourth quarter ...

Baxter International Inc.’s Marion plant is now producing a limited amount of IV solutions, the manufacturer said Thursday.

Baxter International restarted its highest-throughput intravenous solutions manufacturing line at its hurricane-hit North Cove facility in North Carolina, the company announced Thursday.

Otsuka’s IV solutions subsidiary, Otsuka Pharmaceutical Factory, is breaking into the North American market with the help of ...

Baxter International cut its annual profit forecast on Friday due to a hurricane-related hit to its intravenous solutions facility, sending its shares down 3.3% in premarket trading.

Baxter announced this week that it has restarted the highest-throughput IV solutions manufacturing line at its North Cove ...

Baxter International's Q3 2024 adjusted EPS of $0.80 beat estimates, driven by strong Medical Products & Therapies sales and ...